JXSB2200064 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-06-03 | | | | | view |
JYSB2101079 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products | Supplementary Application | 2021-07-08 | | | | | view |
JYSB2400022 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products | Supplementary Application | 2024-02-01 | | | | | view |
JXSS1900059 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products | Import Drug Application | 2019-09-28 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2019-09-27 | view |
JYSB2200008 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products | Supplementary Application | 2022-01-18 | | | | | view |
JXSB2300101 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-08-16 | | | | | view |
JXSL2101130 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-16 | | | | | view |
JXSL2000162 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-09-27 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-09-25 | view |
JXSB2200102 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-08-24 | | | | | view |
JXSL2200165 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-09-15 | | | | | view |
JYSB2000165 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products | Supplementary Application | 2020-05-11 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-10 | view |
JXSB2101063 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-09-26 | | | | | view |
JXSL2101044 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-06-22 | | | | | view |
JYSB2400034 | 奥妥珠单抗注射液 | obinutuzumab | Injection | Biological Products | Supplementary Application | 2024-02-19 | | | | | view |